Viewing nowLafidum Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

MFDS item code 200101103 · Notified 2001.03.22 · Insurance code 657200140
Treatment of onychomycosis, dermatomycosis (such as tinea pedis and tinea corporis), and tinea capitis
This medication is used for the treatment of athlete's foot, tinea corporis, tinea cruris, and onychomycosis caused by dermatophytes in adults, as well as tinea capitis in children.
Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. In patients with infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. Three months is usually sufficient to treat toenail infections, but treatment may take 6 months or longer in some patients. The treatment period may be longer in patients with slow nail growth. In patients with creatinine clearance below 50 mL/min, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. As there is no experience with administration to children under 2 years of age, use is not recommended. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for the prescribed period. Body weight below 20 kg (under 5 years): Administer 62.5 mg once daily. As experience with treatment is limited, the decision to administer should be made after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.
This medicine is not recommended for patients with chronic or active liver diseases. You must check for a history of liver disease before using this medication. Liver function tests should be performed regularly before and during treatment, as liver function abnormalities may occur. If liver function test results increase, discontinue the medication immediately. If symptoms such as nausea, reduced appetite, fatigue, vomiting, upper abdominal pain, jaundice, dark urine, and loose stools occur during treatment, notify your doctor right away. Serious liver damage such as liver failure can occur rarely, so testing should be done immediately if liver function problems are suspected. This medication should not be used if you are allergic to it or its components. Patients with blood disorders, severe renal failure, infants under 2 years of age, and nursing mothers should not take this medicine. Patients with lactose intolerance should also avoid this medication. Caution should be exercised when administering this drug to patients with decreased kidney function, elderly patients, and children weighing less than 20 kg. If severe skin rash or allergic reactions occur during the medication, discontinue it immediately and consult your doctor. This medication should only be used for fungal infections that are difficult to treat topically, and caution is needed when driving or operating machinery if dizziness occurs. There may be interactions with other medications, so consult your doctor or pharmacist if you are taking any other medications. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits of this medication, and nursing mothers should discontinue breastfeeding while using this drug. In case of overdose, symptoms may include headache, nausea, abdominal pain, dizziness, and immediate medical attention is necessary. This medicine should be kept out of reach of children and stored at room temperature away from direct sunlight.
Hepatic and biliary system failure, hepatitis, cholestasis, jaundice, rash, itching, fever, nausea, vomiting, loss of appetite, malaise, γ-GTP elevation, AST/ALT elevation, LDH elevation, ALP elevation, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasiform rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, CPK elevation, serum myoglobin elevation, urinary myoglobin elevation, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasis, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory disturbances, decreased sensation, decreased attention, insomnia, BUN elevation, frequent urination, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated serum total cholesterol, increased triglyceride levels, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent anosmia, olfactory dysfunction, hyposmia, drug rash associated with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is also advisable to store the medicine at a cool room temperature, specifically between 1°C and 30°C.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.